1921
Volume 82, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

The aim of this study was to investigate the factors associated with acute kidney injury (AKI) in patients with visceral leishmaniasis (VL). The study patients had a diagnosis of VL and were admitted to a tertiary hospital. A multivariate analysis was performed to analyze the risk factors for AKI. A total of 224 patients were included. The mean age was 36 ± 15 years. AKI was observed in 33.9% of cases. Risk factors associated with AKI were male gender (odds ratio [OR] = 2.2; = 0.03), advanced age (OR = 1.05; < 0.001), and jaundice (OR = 2.9; = 0.002). There was an association between amphotericin B use and AKI (OR = 18.4; < 0.0001), whereas glucantime use was associated with lower incidence of AKI compared with amphotericin B use (OR = 0.05; < 0.0001). Mortality was 13.3%, and it was higher in AKI patients (30.2%). Therefore, factors associated with AKI were male gender, advanced age, and jaundice. Amphotericin B was an important cause of AKI in VL.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2010.09-0571
2010-03-01
2017-09-19
Loading full text...

Full text loading...

/deliver/fulltext/14761645/82/3/449.html?itemId=/content/journals/10.4269/ajtmh.2010.09-0571&mimeType=html&fmt=ahah

References

  1. Herwaldt BL, , 1999. Leishmaniasis. Lancet 354: 11911199.[Crossref]
  2. Efstratiadis G, Boura E, Giamalis P, Mandala E, Leontsini M, Tsiaousis G, Memmos D, , 2006. Renal involvement in a patient with visceral leishmaniasis. Nephrol Dial Transplant 21: 235236.[Crossref]
  3. Guerin PJ, Olliaro P, Sundar S, Boelaert M, Croft SL, Desjeux P, Wasunna MK, Bryceson AD, , 2002. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2: 494501.[Crossref]
  4. Camargo LB, Langoni H, , 2006. Impact of leishmaniasis on public health. Trop Dis 12: 527548.
  5. Dantas-Torres F, Brandão-Filho SP, , 2006. Visceral leishmaniasis in Brazil: revisiting paradigms of epidemiology and control. Rev Inst Med Trop Sao Paulo 48: 151156.[Crossref]
  6. Boakye DA, Wilson MD, Kweku M, , 2005. A review of leishmaniasis in west Africa. Ghana Med J 39: 9497.
  7. Salgado Filho N, Ferreira TMAF, Costa JML, , 2003. Involvement of the renal function in patients with visceral leishmaniasis (kala-azar). Rev Soc Bras Med Trop 36: 217221.[Crossref]
  8. Oliveira AL, Brustoloni YM, Fernandes TD, Dorval ME, Cunha RV, Bóia MN, , 2009. Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil. Trop Doct 39: 180182.[Crossref]
  9. Daher EF, Evangelista LF, Silva Júnior GB, Lima RS, Aragão EB, Arruda GA, Galeano NM, Mota RM, Oliveira RA, Silva SL, , 2008. Clinical presentation and renal evaluation of human visceral leishmaniasis (kala-azar): a retrospective study of 57 patients in Brazil. Braz J Infect Dis 12: 329332.[Crossref]
  10. Beltrame A, Arzese A, Camporese A, Rorato G, Crapis M, Tarabini-Castellani G, Boscutti G, Pizzolitto S, Calianno G, Matteelli A, Di Muccio T, Gramiccia M, Viale P, , 2008. Acute renal failure due to visceral leishmaniasis by Leishmania infantum successfully treated with a single high dose of liposomal amphotericin B. J Travel Med 15: 358360.[Crossref]
  11. Navarro M, Bonet J, Bonal J, Romero R, , 2006. Secondary amyloidosis with irreversible acute renal failure caused by visceral leishmaniasis in a patient with AIDS. Nefrologia 26: 745746.
  12. Rollino C, Bellis D, Beltrame G, Basolo B, Montemagno A, Bucolo S, Ferro M, Quattrocchio G, Coverlizza S, Quarello F, , 2003. Acute renal failure in leishmaniasis. Nephrol Dial Transplant 18: 19501951.[Crossref]
  13. Ricci Z, Cruz D, Ronco C, , 2008. The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int 73: 538546.[Crossref]
  14. Lima Verde FA, Lima Verde IA, Silva Junior GB, Daher EF, Lima Verde EM, , 2007. Evaluation of renal function in human visceral leishmaniasis (kala-azar): a prospective study of 50 patients from Brazil. J Nephrol 20: 430436.
  15. Pisoni R, Wille KM, Tolwani AJ, , 2008. The epidemiology of severe acute kidney injury. From BEST to PICARD, in acute kidney injury: new concepts. Nephron Clin Pract 109: c188c191.[Crossref]
  16. Lima Verde FAA, Lima Verde FA, Daher EF, Santos GM, Sabóia Neto A, Lima Verde EM, , 2009. Renal tubular dysfunction in human visceral leishmaniasis (kala-azar). Clin Nephrol 71: 492500.[Crossref]
  17. Weisinger JR, Pinto A, Velasquez GA, Bronstein I, Dessene JJ, Duque JF, Montenegro J, Tapanes F, de Rousse AR, , 1978. Clinical and histological kidney involvement in human kala-azar. Am J Trop Med Hyg 2: 357359.
  18. Martinelli R, Lourenzo R, Rocha H, , 1986. Absence of clinical abnormalities suggesting renal involvement during long-term course of visceral leishmaniasis. Rev Soc Bras Med Trop 19: 209212.[Crossref]
  19. Tafuri WL, Michalik MSM, Dias M, Genaro O, Leite VHR, Barbosa AJA, Bambirra EA, Costa CA, Melo MN, Mayrink W, , 1989. Estudo ao microscópio óptico e eletrônico do rim de cães natural e experimentalmente infectados com Leishmania chagasi . Rev Inst Med Trop Sao Paulo 31: 139145.[Crossref]
  20. Prasad LS, Sen S, Ganguly SK, , 1992. Renal involvement in kala-azar. Indian J Med Res 95: 4346.
  21. Polli A, Abramo F, Mancianti F, Nigro M, Pieri S, Bionda A, , 1991. Renal involvement in canine leishmaniasis. A light microscopic, immunohistochemical and electron microscopic study. Nephron 57: 444452.[Crossref]
  22. Dutra M, Martinelli M, Carvalho EM, Rodrigues LE, Brito E, Rocha H, , 1985. Renal involvement in visceral leishmaniasis. Am J Kidney Dis 6: 2227.[Crossref]
  23. Duvic C, Nedelec G, Debord T, Herody M, Didelot F, , 1999. Important parasitic nephropathies: update from the recent literature. Nephrologie 20: 6574.
  24. Chaigne V, Knefati Y, Lafarge R, Bronner J, McGregor B, Fouque D, Sabatier JC, , 2004. A patient with visceral leishmaniasis and acute renal failure in necrotizing glomerulonephritis. Nephrologie 25: 179183.
  25. Ben Salem L, Khiari K, Turki S, Cherif L, Ali IH, Maazoun I, Ben Moussa F, el Younsi F, Ben Abdallah N, Ben Maïz H, , 2003. Obstructive acute renal failure revealing visceral leishmaniasis in a diabetic patient. Nephrologie 24: 9599.
  26. Clevenberg P, Okome MN, Benoit S, Bendini JC, De Salvador F, Elbeze M, Cassuto E, Marty P, Dellamonica P, , 2002. Acute renal failure as initial presentation of visceral leishmaniasis in an HIV-1 infected patient. Scand J Infect Dis 34: 546547.[Crossref]
  27. Berdichevski RH, Luis LB, Crestana L, Manero RC, , 2006. Amphotericin B-related nephrotoxicity in low-risk patients. Braz J Infect Dis 10: 9499.[Crossref]
  28. Bagnis CI, Deray G, , 2002. Amphotericin B nephrotoxicity. Saudi J Kidney Dis Transpl 13: 481491.
  29. Olliaro PL, Guerin PJ, Gerstl S, Haaskjold AA, Rottingen JA, Sundar S, , 2005. Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980–2004. Lancet Infect Dis 5: 763774.[Crossref]
  30. Werneck GL, Batista MS, Gomes JR, Costa CH, , 2003. Prognostic factors from visceral leishmaniasis in Teresina, Brazil. Infection 31: 174177.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2010.09-0571
Loading
/content/journals/10.4269/ajtmh.2010.09-0571
Loading

Data & Media loading...

  • Received : 20 Sep 2009
  • Accepted : 29 Nov 2009

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error